Trial Profile
Inhaled iloprost in pulmonary hypertension secondary to pulmonary fibrosis
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms TILOPF
- 31 Mar 2007 New trial record.